EPILEPSYGTX

HQ - Canterbury

Summary

EpilepsyGTx is a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 25 M

Avg. Deal Size£ 25 M

Market Context

Senior Management